LoadingLoadingLoadingNet selling: insiders sold $18.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Balyasny
$68.7M
bought
Marshall Wace
$40.3M
added
Sells/Trims (1)
D.E. Shaw
$19.0M
trimmed
No tracked top-trader positions in GKOS as of Oct 24, 08:39 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.28 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 24, 2026
EPS expected
-$0.18 to -$0.02
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | -$0.24 / -$0.28Alpha Vantage | +14.29% beat | $185.6M No estimate | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | -$0.18 / -$0.28Alpha Vantage | +35.71% beat | $150.6M No estimate | Unavailable |
| Dec 31, 2025 | Feb 17, 2026 | -$0.90 / -$0.21Alpha Vantage | -$0.69 miss | $143.1M No estimate | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | -$0.16 / -$0.26Alpha Vantage | +38.46% beat | $133.5M No estimate | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | -$0.24 / -$0.26Alpha Vantage | +7.69% beat | $124.1M No estimate | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | -$0.22 / -$0.35Alpha Vantage | +37.14% beat | $106.7M No estimate | Unavailable |
| Dec 31, 2024 | Feb 20, 2025 | -$0.40 / -$0.39Alpha Vantage | -2.96% miss | $105.5M No estimate | Unavailable |
| Sep 30, 2024 | Nov 4, 2024 | -$0.28 / -$0.48Alpha Vantage | +41.67% beat | $96.7M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $133.5M | $143.1M | $150.6M | $185.6M |
| Cost of what it sold | $28.8M | $31.8M | $33.3M | $34.0M |
| Gross profit | $104.7M | $111.3M | $117.2M | $151.6M |
| What it spent | ||||
| Research and development | $38.1M | $43.7M | $44.1M | $51.3M |
| Sales and admin | $83.0M | $94.7M | $92.9M | $116.1M |
| Total operating expenses | $121.1M | $138.4M | $137.1M | $168.9M |
| What was left | ||||
| Operating profit | -$16.4M | -$27.0M | -$19.9M | -$17.3M |
| Interest on debt | $1.2M | $1.1M | $1.1M | $1.5M |
| Profit before tax | -$16.0M | -$139.8M | -$19.3M | -$17.7M |
| Tax | $234.0K | -$6.2M | $484.0K | $656.0K |
| Net profit | -$16.2M | -$133.7M | -$19.8M | -$18.4M |
| EBITDA | -$4.6M | -$125.4M | -$5.3M | -$5.6M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
BTIG raises target for Glaukos stock to USD 205
BullishOct 20Stifel reiterates USD 190.00 target for Glaukos stock, 15.26 percent above price
BullishOct 17Stifel reiterates Glaukos stock rating on strong iDose growth
BullishOct 16Stifel reiterates Glaukos stock rating on strong iDose growth
BullishOct 16Glaukos Corporation (GKOS) Reiterated at Buy by Stifel After Solid Q3 iDose Volume Diligence
BullishOct 16Glaukos Corporation (GKOS) Stock Price, News, Quote & History
Leans bullishOct 16Mizuho lifts target for Glaukos stock to USD 190.00
Leans bullishOct 15Glaukos reports positive topline phase 4 data on iDose TR in combo with cataract surgery
BullishOct 15
